OBJECTIVE: To examine the association of single nucleotide polymorphisms (SNPs) of the CHRNB3 (rs13280604) and CHRNA6 (rs892413) nicotinic acetylcholine receptor (nAChR) genes and symptoms of attention deficit hyperactivity disorder (ADHD) in predicting smoking patterns from early adolescence to adulthood. METHOD: A longitudinal cohort of 1137 unrelated youths from the National Longitudinal Study of Adolescent Health provided responses to four surveys from Waves I to IV, and a genetic sample in Wave III. Growth mixture modeling was used to identify smoking patterns and to assess the effects of the two SNPs and ADHD symptoms on cigarette use over time. RESULTS: There were significant main effects of ADHD symptoms and CHRNA6 variants in predicting the number of cigarettes smoked and the pattern of use over time, respectively. There were no main effects of the CHRNB3 variants. However, a significant CHRNB3 variant×ADHD symptom interaction was observed, such that individuals with elevated ADHD symptoms and a particular CHRNB3 variant were at increased risk of cigarette use over time. CONCLUSIONS: These findings demonstrate that a SNP in a nicotinic receptor gene may interact with ADHD symptoms to link with increased cigarette use across adolescence and young adulthood. Unique associations between specific variants and patterns of ADHD symptoms were identified which may be useful for targeting prevention efforts to individuals at greatest risk for cigarette smoking.
OBJECTIVE: To examine the association of single nucleotide polymorphisms (SNPs) of the CHRNB3 (rs13280604) and CHRNA6 (rs892413) nicotinic acetylcholine receptor (nAChR) genes and symptoms of attention deficit hyperactivity disorder (ADHD) in predicting smoking patterns from early adolescence to adulthood. METHOD: A longitudinal cohort of 1137 unrelated youths from the National Longitudinal Study of Adolescent Health provided responses to four surveys from Waves I to IV, and a genetic sample in Wave III. Growth mixture modeling was used to identify smoking patterns and to assess the effects of the two SNPs and ADHD symptoms on cigarette use over time. RESULTS: There were significant main effects of ADHD symptoms and CHRNA6 variants in predicting the number of cigarettes smoked and the pattern of use over time, respectively. There were no main effects of the CHRNB3 variants. However, a significant CHRNB3 variant×ADHD symptom interaction was observed, such that individuals with elevated ADHD symptoms and a particular CHRNB3 variant were at increased risk of cigarette use over time. CONCLUSIONS: These findings demonstrate that a SNP in a nicotinic receptor gene may interact with ADHD symptoms to link with increased cigarette use across adolescence and young adulthood. Unique associations between specific variants and patterns of ADHD symptoms were identified which may be useful for targeting prevention efforts to individuals at greatest risk for cigarette smoking.
Authors: M R Spitz; H Shi; F Yang; K S Hudmon; H Jiang; R M Chamberlain; C I Amos; Y Wan; P Cinciripini; W K Hong; X Wu Journal: J Natl Cancer Inst Date: 1998-03-04 Impact factor: 13.506
Authors: C Lerman; J Audrain; K Tercyak; L W Hawk; A Bush; S Crystal-Mansour; C Rose; R Niaura; L H Epstein Journal: Nicotine Tob Res Date: 2001-11 Impact factor: 4.244
Authors: Caryn Lerman; Peter G Shields; E Paul Wileyto; Janet Audrain; Larry H Hawk; Angela Pinto; Susan Kucharski; Shiva Krishnan; Ray Niaura; Leonard H Epstein Journal: Health Psychol Date: 2003-09 Impact factor: 4.267
Authors: Janet Audrain-McGovern; Caryn Lerman; E Paul Wileyto; Daniel Rodriguez; Peter G Shields Journal: Am J Psychiatry Date: 2004-07 Impact factor: 18.112
Authors: Beth Wilmot; Rebecca Fry; Lisa Smeester; Erica D Musser; Jonathan Mill; Joel T Nigg Journal: J Child Psychol Psychiatry Date: 2015-08-25 Impact factor: 8.982
Authors: Evelise R Polina; Diego L Rovaris; Lucas A de Azeredo; Nina R Mota; Eduardo S Vitola; Katiane L Silva; Paula O Guimarães-da-Silva; Felipe A Picon; Paulo Belmonte-de-Abreu; Luis A Rohde; Eugenio H Grevet; Claiton H D Bau Journal: Neuromolecular Med Date: 2013-12-28 Impact factor: 3.843
Authors: Maria Niarchou; Julia M Sealock; Peter Straub; Sandra Sanchez-Roige; James S Sutcliffe; Lea K Davis Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2022-07-15 Impact factor: 3.358